<p>Abbreviation: CNS, central nervous system; ICD-9-CM, <i>International Classification of Disease, Ninth Revision, Clinical Modification</i>; IP, inpatient; ED, emergency department; OP, outpatient.</p>a<p>Exclude if associated with any of the following within 0–7 days after encephalitis/myelitis diagnoses: 047.0, 047.1, 048, 049.0–049.8, 053*–056*, 058*.</p>b<p>Exclude if associated with any of the following on the same day of idiopathic thrombocytopenia diagnoses: 140*–208*, 228*, 279*, 283*, 284*, 286.6, 570*, 571*, 742.59.</p
The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) system is a cohort-based active surv...
The emergence of pandemic H1N1 influenza in 2009 has prompted public health responses, including pro...
We sought to determine the range and extent of neurologic complications due to pandemic influenza A ...
<p>Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...
<p>Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...
BackgroundAdverse events occurring after vaccination are routinely reported to the Vaccine Adverse E...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
Objectives To review neurological complications after the influenza A (H1N1) pdm09, highlighting the...
Objective: To characterize the incidence and spectrum of neurological adverse events (AE) after COVI...
Serious adverse events after immunizations are rare. We review the case of a man who, 50 years earli...
Background: With the advent of live-attenuated, quadrivalent, and cell-cultured vaccines for influen...
In Taiwan, new H1N1 monovalent vaccines without adjuvant and with MF59H adjuvant were used in the na...
The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) system is a cohort-based active surv...
The emergence of pandemic H1N1 influenza in 2009 has prompted public health responses, including pro...
We sought to determine the range and extent of neurologic complications due to pandemic influenza A ...
<p>Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...
<p>Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...
BackgroundAdverse events occurring after vaccination are routinely reported to the Vaccine Adverse E...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
Objectives To review neurological complications after the influenza A (H1N1) pdm09, highlighting the...
Objective: To characterize the incidence and spectrum of neurological adverse events (AE) after COVI...
Serious adverse events after immunizations are rare. We review the case of a man who, 50 years earli...
Background: With the advent of live-attenuated, quadrivalent, and cell-cultured vaccines for influen...
In Taiwan, new H1N1 monovalent vaccines without adjuvant and with MF59H adjuvant were used in the na...
The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) system is a cohort-based active surv...
The emergence of pandemic H1N1 influenza in 2009 has prompted public health responses, including pro...
We sought to determine the range and extent of neurologic complications due to pandemic influenza A ...